TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Laerdal Medical AS
Closing information (x1000 SEK)
| Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Turnover |
5,577,823
|
4,556,577
|
3,850,962 |
| Financial expenses |
3,887
|
-974
|
7,893 |
| Earnings before taxes |
905,622
|
852,938
|
579,632 |
| Total assets |
5,521,808
|
4,662,206
|
3,693,175 |
| Current assets |
4,289,067
|
3,693,231
|
2,835,149 |
| Current liabilities |
1,992,632
|
1,807,182
|
1,275,025 |
| Equity capital |
3,082,986
|
2,490,552
|
2,172,495 |
| - share capital |
17,114
|
16,599
|
15,452 |
Financial ratios
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Solvency |
55.8%
|
53.4%
|
58.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
16.2%
|
18.7%
|
15.1% |
| Return on assets (ROA) |
16.5%
|
18.3%
|
15.9% |
| Current ratio |
215.2%
|
204.4%
|
222.4% |
| Return on equity (ROE) |
29.4%
|
34.2%
|
26.7% |
| Change turnover |
880,058
|
419,803
|
164,940 |
| Change turnover % |
19%
|
10%
|
4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.